We are live on ! Find out more
LAB icon

Standard BioTools
LAB

81 hedge funds and large institutions have $217M invested in Standard BioTools in 2017 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 34 increasing their positions, 22 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 22

19% more capital invested

Capital invested by funds: $182M → $217M (+$35.1M)

18% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 11

1% more funds holding

Funds holding: 80 → 81 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6% less call options, than puts

Call options by funds: $283K | Put options by funds: $300K

28.09% less ownership

Funds ownership: 123.1% → 95.01% (-28%)

Holders
81
Holders Change
+1
Holders Change %
+1.25%
% of All Funds
1.84%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
34
Reduced
22
Closed
11
Calls
$283K
Puts
$300K
Net Calls
-$17K
Net Calls Change
-$114K

Top Buyers

1
LCS
Levin Capital Strategies
New York
+$2.54M
2
Russell Investments Group
Russell Investments Group
United Kingdom
+$2.1M
3
BlackRock
BlackRock
New York
+$1.85M
4
AC
Alexandria Capital
Virginia
+$1.03M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$759K

Top Sellers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$3.54M
2
Neuberger Berman Group
Neuberger Berman Group
New York
-$2.56M
3
O
OrbiMed
New York
-$889K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$538K
5
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
-$391K
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$816K +$137K +25,074 +22%
IP
27
Intellectus Partners
California
$799K – – –
PCM
28
Perkins Capital Management
Minnesota
$781K +$726K +132,650 New
Two Sigma Investments
29
Two Sigma Investments
New York
$687K +$456K +83,330 +250%
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$599K -$273K -49,961 -33%
TCIM
31
TIAA CREF Investment Management
New York
$506K +$51.7K +9,442 +12%
Morgan Stanley
32
Morgan Stanley
New York
$468K +$223K +40,799 +106%
BCM
33
Bridgeway Capital Management
Texas
$433K -$383K -70,000 -49%
Charles Schwab
34
Charles Schwab
California
$423K +$86.5K +15,800 +28%
JP Morgan Chase
35
JP Morgan Chase
New York
$396K +$6.02K +1,099 +2%
TA
36
Teachers Advisors
New York
$382K +$45.5K +8,319 +15%
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$360K +$70.2K +12,831 +27%
California Public Employees Retirement System
38
California Public Employees Retirement System
California
$320K – – –
Ohio Public Employees Retirement System (OPERS)
39
Ohio Public Employees Retirement System (OPERS)
Ohio
$269K – – –
AllianceBernstein
40
AllianceBernstein
Tennessee
$256K +$11.5K +2,100 +5%
PPA
41
Parametric Portfolio Associates
Washington
$220K -$3.86K -705 -2%
Manulife (Manufacturers Life Insurance)
42
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$193K +$113K +20,570 +167%
OAM
43
Oxford Asset Management
United Kingdom
$184K +$167K +30,513 New
PP
44
PDT Partners
New York
$180K +$13.5K +2,464 +9%
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$165K -$17.8K -3,248 -10%
State Board of Administration of Florida Retirement System
46
State Board of Administration of Florida Retirement System
Florida
$161K – – –
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
$155K – – –
AIG
48
American International Group
New York
$154K +$35.1K +6,414 +33%
Nisa Investment Advisors
49
Nisa Investment Advisors
Missouri
$137K – – –
MIM
50
MetLife Investment Management
New Jersey
$121K +$113K +20,596 New
1
2
3 4

LAB Hedge Fund Activity: Q4 2017 in Review

81 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q4 2017, worth a combined $217M — up 19% from $182M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new LAB positions and 11 closed out — a net gain of 2 holders — while 34 added to existing stakes and 22 trimmed.

The largest buyer was Levin Capital Strategies, adding an estimated $2.54M. The largest seller was Adage Capital Partners, cutting an estimated $3.54M.

  • 81 institutional investors held Standard BioTools (LAB) as of Q4 2017, up from 80 in Q3 2017.
  • Funds reported $217M of Standard BioTools stock for Q4 2017, up 19% quarter-over-quarter.
  • 13 funds opened new Standard BioTools positions in Q4 2017 and 11 closed out, a net change of +2 holders.
  • The largest Standard BioTools buyer in Q4 2017 was Levin Capital Strategies, an estimated $2.54M added.
  • The largest Standard BioTools seller in Q4 2017 was Adage Capital Partners, an estimated $3.54M sold.

Based on aggregated 13F filings for Q4 2017.